The association of diabetes and hyperglycemia with sepsis outcomes: a population-based cohort analysis

被引:0
作者
Yarden Zohar
Shani Zilberman Itskovich
Shlomit Koren
Ronit Zaidenstein
Dror Marchaim
Ronit Koren
机构
[1] Shamir (Assaf Harofeh) Medical Center,Department of Internal Medicine A
[2] Shamir (Assaf Harofeh) Medical Center,Department of Nephrology
[3] Shamir (Assaf Harofeh) Medical Center,Diabetes Unit
[4] Shamir (Assaf Harofeh) Medical Center,Unit of Infection Control
[5] Tel-Aviv University,Sackler Faculty of Medicine
来源
Internal and Emergency Medicine | 2021年 / 16卷
关键词
Diabetes; Hyperglycemia; Sepsis; Community-acquired infections; Multi-drug resistant; MDR;
D O I
暂无
中图分类号
学科分类号
摘要
The independent association of diabetes and hyperglycemia on the outcomes of sepsis remains unclear. We conducted retrospective cohort analyses of outcomes among patients with community-onset sepsis admitted to Shamir Medical Center, Israel (08-12/2016). Statistical associations were queried by Cox and logistic regressions, controlled for by matched propensity score analyses. Among 1527 patients with community-onset sepsis, 469 (30.7%) were diabetic. Diabetic patients were significantly older, with advanced complexity of comorbidities, and were more often exposed to healthcare environments. Despite statistically significant univariable associations with in-hospital and 90-day mortality, the adjusted Hazard Ratios (aHR) were 1.21 95% CI 0.8–1.71, p = 0.29 and 1.13 95% CI 0.86–1.49, p = 0.37, respectively. However, hyperglycemia at admission (i.e., above 200 mg/dl (was independently associated with: increased in-hospital mortality, aHR 1.48 95% CI 1.02–2.16, p = 0.037, 30-day mortality, aHR 1.8 95% CI 1.12–2.58, p = 0.001), and 90-day mortality, aHR 1.68 95% CI 1.24–2.27, p = 0.001. This association was more robust among diabetic patients than those without diabetes. In this study, diabetes was not associated with worse clinical outcomes in community-onset sepsis. However, high glucose levels at sepsis onset are independently associated with a worse prognosis, particularly among diabetic patients. Future trials should explore whether glycemic control could impact the outcomes and should be part of the management of sepsis, among the general adult septic population.
引用
收藏
页码:719 / 728
页数:9
相关论文
共 367 条
[1]  
Ogurtsova K(2017)IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040 Diabetes Res Clin Pract 128 40-50
[2]  
da Rocha Fernandes JD(2001)Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med 29 1303-1310
[3]  
Huang Y(2014)Epidemiology of severe sepsis Virulence 5 4-11
[4]  
Linnenkamp U(2003)Quantifying the risk of infectious diseases for people with diabetes Diabetes Care 26 510-513
[5]  
Guariguata L(2011)Diabetes mellitus, fasting glucose, and risk of cause-specific death N Engl J Med 364 829-841
[6]  
Cho NH(2011)Diabetes and sepsis: preclinical findings and clinical relevance Diabetes Care 34 771-778
[7]  
Cavan D(2002)Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study Intensive Care Med 28 108-121
[8]  
Shaw JE(2008)Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study Diabetes Care 31 1541-1545
[9]  
Makaroff LE(2016)Diabetes and infection: assessing the association with glycaemic control in population-based studies Lancet Diabetes Endocrinol 4 148-158
[10]  
Angus DC(2008)Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia Blood 112 82-89